Investing

Kymera Therapeutics : KYMR

KYMR

Stock Data

$80.71

$0.36 (0.44%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Kymera Therapeutics Inc is a pioneering biopharmaceutical firm based in Watertown, Massachusetts, dedicated to creating innovative small molecule treatments. By leveraging the body's protein degradation system, Kymera aims to eliminate disease-causing proteins. Its research spans various areas, including immunology, oncology, and autoimmune diseases, with notable projects like the IRAK4 program for inflammatory conditions, STAT3 and MDM2 for cancer, as well as STAT6 and TYK2 targeting allergic and autoimmune diseases. Founded in 2015, Kymera is at the forefront of developing groundbreaking therapies.

All Kymera Therapeutics Articles

5 Articles

Trey Thoelcke | Apr 1, 2026 at 7:05 AM EDT

5 Biotechs That Big Pharma Could Snap Up as Oncology M&A Heats Up

Oncology M&A activity is accelerating as large pharmaceutical companies race to replenish pipelines facing patent cliffs and seek exposure to…

William Temple | Mar 9, 2026 at 10:38 PM EDT

Kymera CEO Nello Mainolfi’s Boldest Line Had Nothing to Do With the Earnings Miss

Kymera Therapeutics (NASDAQ:KYMR) CEO Nello Mainolfi had one line on the February 26, 2026 earnings call that deserves attention beyond…

Trey Thoelcke | Dec 30, 2025 at 8:45 AM EST

The Biggest IPO of the Year Prompts Huge Insider Buy

Kodiak Sciences, Medline, and W.R. Berkley have seen some huge insider purchases, and there were some other notable insider purchases…

Trey Thoelcke | Dec 17, 2025 at 8:45 AM EST

Share Offerings Prompt Huge Insider Buying in These 3 Biotechs

Secondary offerings from biotechs Immunovant, Kymera Therapeutics, and Wave Life Sciences prompted some huge insider buying recently.

Lee Jackson | Nov 26, 2025 at 8:06 AM EST

Here Are Wednesday’s Top Wall Street Analyst Research Calls: DHL Group, NetApp, Nutanix, Oracle, Snowflake, Urban Outfitters, Zscaler and More

Pre-Market Stock Futures: The futures are trading modestly higher as Thanksgiving Eve has finally arrived. After a slow start on…